Jacques E. Chelly
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Jacques E. Chelly sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Jacques E. Chelly: 10 sponsored US clinical trials, 3 recruiting.
Jacques E. Chelly sponsors 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Nasogastric Tube Intubation, with 1 trials.
Top-decile sponsor footprint
Jacques E. Chelly ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
Vagal Stimulator to Reduce Nasogastric Tube Use
NCT06648759
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
NCT05506878
Auriculotherapy in the Treatment of Pre-Operative Anxiety
NCT04836936
NEUROCUPLE™ as an Opioid Alternative Following Total Knee Arthroplasty
NCT07439666
A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery
NCT05252858
Auriculotherapy for Surgical Pain
NCT03860259
Perioperative Ketamine in Opioid-Tolerant Patients Undergoing Lumbar Spine Surgery
NCT04220489
NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries
NCT03834142
NSS-2 BRIDGE Device in Post-Operative Pain Management
NCT03555266
A Pain Study Comparing Two Commonly Used Medications to Treat Pain After Bowel Surgery
NCT02849678
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Jacques E. Chelly pipeline
3 recruiting of 10 indexed (30% open); 5 completed (50%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Nasogastric Tube Intubation (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Jacques E. Chelly: open-pipeline peers nationwide
Peers matched on 10 registered trials and 30% open enrollment, not the therapeutic-area sidebar.
Jacques E. Chelly sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 30% open enrollment (± trial volume)
- Centre hospitalier de l'Université de Montréal (CHUM) · 30% recruiting · 10 trials
- Child Trends · 30% recruiting · 10 trials
- Jason Sperry · 30% recruiting · 10 trials
- Medtronic Cardiac Ablation Solutions · 30% recruiting · 20 trials
Related
What to do with this Jacques E. Chelly page
10 registered trials is a research-attention snapshot, not an endorsement of Jacques E. Chelly or any single study.
- 3 of Jacques E. Chelly's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Nasogastric Tube Intubation is the condition Jacques E. Chelly studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Nasogastric Tube Intubation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Jacques E. Chelly pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.